<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02855827</url>
  </required_header>
  <id_info>
    <org_study_id>P/2013/170</org_study_id>
    <nct_id>NCT02855827</nct_id>
  </id_info>
  <brief_title>Constitution of a Cohort for Monitoring Patients Candidating for Ovarian Tissue Autograft</brief_title>
  <acronym>PERIDATOR</acronym>
  <official_title>Constitution of a Cohort for Monitoring Patients Candidating for Ovarian Tissue Autograft</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CHU de Reims</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Marseille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CMCO SIHCUS, Schiltingheim</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Limoges</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ovarian cryopreservation is one of the available option for preserving fertility prior to
      potentially sterilizing treatments. In the absence of other techniques such as in vitro
      folliculogenesis or injection of isolated ovarian follicles, this tissue can only be re-used
      by autograft. In France, the first live birth after orthotopic ovarian transplantation, was
      obtained by Roux et al. in 2009.

      This clinical trial aims to build a cohort of patients likely to use their ovarian tissue
      cryopreserved by autograft.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ovarian cryopreservation is one of the available option for preserving fertility prior to
      potentially sterilizing treatments. In the absence of other techniques such as in vitro
      folliculogenesis or injection of isolated ovarian follicles, this tissue can only be re-used
      by autograft. In France, the first live birth after orthotopic ovarian transplantation, was
      obtained by Roux et al. in 2009.

      This clinical trial aims to build a cohort of patients likely to use their ovarian tissue
      cryopreserved by autograft. This cohort will be used to:

        -  Follow up of patients with their cryopreserved ovarian tissue;

        -  Evaluate requests for ovarian tissue grafting ;

        -  Propose a search of residual disease in case of neoplastic disease risk (if possible);

        -  Allowing patients to benefit from an ovarian tissue autograft;

        -  Assess the effectiveness of autograft technique after the restoration of ovarian
           function.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patient who are candidate to ovarian tissue autograft</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Ovarian Function Insufficiency</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients likely to re-use their ovarian tissue cryopreserved by autograft
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who have cryopreserved their ovarian tissue;

          -  Patients with premature ovarian insufficiency;

          -  Patients older than 11 years (bone age) for induction of puberty;

          -  Patients aged from 18 to 43 years for the restoration of ovarian function;

          -  No objection from the patient

          -  Patients who have already received ovarian tissue autograft.

        Exclusion Criteria:

          -  Patients aged under 11 years (bone age);

          -  Patients older than 43 years;

          -  Patients refusing to be included;

          -  Patients (adults) under guardianship, curators and safeguard justice
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>43 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chlotilde AMIOT, MD, PhD</last_name>
    <email>camiot@chu-besancon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU Besancon</name>
      <address>
        <city>Besan√ßon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clotilde AMIOT, PhD, MD</last_name>
      <phone>+33 3 81 21 86 81</phone>
      <email>clotilde.amiot@univ-fcomte.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Roux C, Amiot C, Agnani G, Aubard Y, Rohrlich PS, Piver P. Live birth after ovarian tissue autograft in a patient with sickle cell disease treated by allogeneic bone marrow transplantation. Fertil Steril. 2010 May 1;93(7):2413.e15-9. doi: 10.1016/j.fertnstert.2009.12.022. Epub 2010 Feb 1.</citation>
    <PMID>20117783</PMID>
  </reference>
  <reference>
    <citation>Amiot C, Angelot-Delettre F, Zver T, Alvergnas-Vieille M, Saas P, Garnache-Ottou F, Roux C. Minimal residual disease detection of leukemic cells in ovarian cortex by eight-color flow cytometry. Hum Reprod. 2013 Aug;28(8):2157-67. doi: 10.1093/humrep/det126. Epub 2013 Apr 30.</citation>
    <PMID>23633552</PMID>
  </reference>
  <reference>
    <citation>Fauque P, Ben Amor A, Joanne C, Agnani G, Bresson JL, Roux C. Use of trypan blue staining to assess the quality of ovarian cryopreservation. Fertil Steril. 2007 May;87(5):1200-7. Epub 2007 Feb 20.</citation>
    <PMID>17307173</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2016</study_first_submitted>
  <study_first_submitted_qc>August 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2016</study_first_posted>
  <last_update_submitted>January 25, 2018</last_update_submitted>
  <last_update_submitted_qc>January 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

